Blood · 1996 · 40 citations · 31 references
MedicineImmunologyOncologyCancer ImmunologyNeoplasiaTumor ImmunologyBone Marrow PathologyHematologic PathologyLymphoid NeoplasmsLymphoid Tissue PathologyLymphoid TumorsTumor ImmunopathologyLymphoid Neoplasm PathogenesisLymphoma Bone Marrow InvolvementLymphoma Pathogenesis
Shiga-like toxin-1 (SLT-1) is a bacterial toxin that kills cells by inhibiting protein synthesis. SLT-1 is composed of one cytotoxic A-subunit and five B-subunits that bind to CD77, a cell-surface glycolipid. In the human hematopoietic system, CD77 expression is restricted to a subset of activated B cells and derived cancers. Here we report that SLT-1 treatment of murine bone marrow ex vivo effectively cures severe combined immunodeficient mice of a human B-cell lymphoma xenograft while sparing normal hematopoietic precursor cells. Flow cytometry results using fluorescein isothiocyanate-labeled SLT-1 B-subunit show the high prevalence of expression of SLT-1 receptors (CD77) in human non-Hodgkin's lymphomas, especially follicular lymphomas. These results suggest the use of SLT-1 for the purging of human bone marrow before autologous bone marrow transplant in the case of CD77+ B-cell lymphomas as just one of many possible uses.
31
A severe combined immunodeficiency mutation in the mouse
Gayle C. Bosma, R. Philip Custer, Melvin J. Bosma · Nature · 1983 · 2.2K citations
Life Sciences, Genetics, Immunology +12
XG Zhang, JP Gaillard, N Robillard et al. · Blood · 1994 · 273 citations · Full text
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Marianne Mangeney, Clifford A. Lingwood, Samir Taga et al. · PubMed · 1993 · 236 citations
CD77: an antigen of germinal center B cells entering apoptosis
Marianne Mangeney, Yolande Richard, Dominique Coulaud et al. · European Journal of Immunology · 1991 · 186 citations